Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mocetinostat + Gemcitabine in Solid Tumors and Pancreatic Cancer
NCT00372437Phase 2Completed
- Sponsor
- Mirati Therapeutics
- Start
- Sep 2006
- Primary completion
- Dec 2008
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of mocetinostat in pancreatic cancer (PC), solid tumor, sponsored by Mirati Therapeutics. Started Sep 2006; status: completed.
02
Drugs
mocetinostat
03
Conditions
pancreatic cancer (PC)solid tumor
Beyond the preview
Go deeper on NCT00372437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00372437.